Target (CBDY) Total Non-Current Liabilities (2019 - 2026)

Target (CBDY) reported Total Non-Current Liabilities of $795392.0 for Q1 2026, down 15.93% year-over-year from $946124.0 in Q1 2025, and down 7.31% quarter-over-quarter from $858088.0 in Q4 2025.

Target (CBDY) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

Target (CBDY) has 8 years of Total Non-Current Liabilities data on file, last reported at $795392.0 in Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $795392.0, down 15.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $795392.0 (down 15.93% YoY), and the FY2025 annual result was $858088.0, down 12.86% from the prior year.
  • Total Non-Current Liabilities retreated to $795392.0 in Q1 2026 per CBDY's latest filing, from $858088.0 in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $10.8 million in Q1 2022 and troughed at $795392.0 in Q1 2026.
  • A 5-year average of $4.0 million and a median of $1.2 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities slumped 85.3% in 2024, then soared 228.28% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $7.2 million in 2022, then sank by 82.99% to $1.2 million in 2023, then slipped by 19.57% to $984733.0 in 2024, then dropped by 12.86% to $858088.0 in 2025, then declined by 7.31% to $795392.0 in 2026.
  • Business Quant data shows CBDY's Total Non-Current Liabilities at $795392.0 in Q1 2026, $858088.0 in Q4 2025, and $890579.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 18.28 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.44 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.81 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.13 Bn
10 Target - - 191,787.00 795,392.00

Historic Data

Download Data
DateValue
Mar 31, 2026 795,392.00
Dec 31, 2025 858,088.00
Sep 30, 2025 890,579.00
Jun 30, 2025 3.65 Mn
Mar 31, 2025 946,124.00
Dec 31, 2024 984,733.00
Sep 30, 2024 1.09 Mn
Jun 30, 2024 1.11 Mn
Mar 31, 2024 1.16 Mn
Dec 31, 2023 1.22 Mn
Sep 30, 2023 6.77 Mn
Jun 30, 2023 7.56 Mn
Mar 31, 2023 7.29 Mn
Dec 31, 2022 7.20 Mn
Sep 30, 2022 7.01 Mn
Jun 30, 2022 9.46 Mn
Mar 31, 2022 10.83 Mn
Dec 31, 2021 11.17 Mn
Sep 30, 2021 11.43 Mn
Jun 30, 2021 13.46 Mn